1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Biodefense Industry Report 2015

Global Biodefense Industry Report 2015

  • December 2015
  • -
  • QY Research Group
  • -
  • 144 pages

Summary

The Global Biodefense Industry Report 2015 is a professional and in-depth study on the current state of the Biodefense industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biodefense market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biodefense industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 166 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table Of Contents

Global Biodefense Industry Report 2015
Table of Contents

1 Industry Overview 1
1.1 Definition and Specifications of Biodefense 1
1.2 Classification of Biodefense 2
1.3 Applications of Biodefense 4
1.4 Industry Regional Overview of Biodefense 5
1.5 Industry Policy Analysis of Biodefense 6
1.6 Industry News Analysis of Biodefense 8
2 Description of Major Biodefense Threat 10
2.1 Anthrax 10
2.2 Smallpox 11
2.3 Botulism 13
2.4 Radiation 15
2.5 Others 15
3 Technical Data and Manufacturing Plants Analysis 18
3.1 Revenue and Establish Time of Global Key Manufacturers in 2015 18
3.2 Manufacturing Plants Distribution of Global Key Biodefense Manufacturers in 2015 19
3.3 Major Product of Global Biodefense Key Manufacturers in 2015 20
4 Global Biodefense Market Analysis by Product 2010-2015 21
4.1 Global Biodefense Market Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) 2010-2015 21
4.2 Global Biodefense against Anthrax Market Analysis 2010-2015 28
4.3 Global Biodefense against Smallpox Market Analysis 2010-2015 29
4.4 Global Biodefense against Botulism Market Analysis 2010-2015 30
4.5 Global Biodefense against Radiation/Nuclear Market Analysis 2010-2015 31
5 Global Biodefense Market Analysis by Segment 2010-2015 32
5.1 Global Biodefense Market Analysis by Segment (USA Civilian, USA Military, Non-USA Market) 2010-2015 32
5.2 USA Civilian Biodefense Market Analysis 2010-2015 39
5.3 USA Military Biodefense Market Analysis 2010-2015 40
5.4 Non-USA Market Biodefense Analysis 2010-2015 41
6 Analysis of Biodefense Revenue and Market Status 2010-2015 42
6.1 Revenue of Biodefense 2010-2015 42
6.2 Gross Margin of Biodefense 2010-2015 50
6.3 Market Size Overview of Biodefense 2010-2015 53
7 Analysis of Biodefense Industry Key Manufacturers 54
7.1 Emergent Biosolutions 54
7.1.1 Company Profile 54
7.1.2 Product Information 55
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 56
7.2 Hytest 57
7.2.1 Company Profile 57
7.2.2 Product Information 59
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 59
7.3 GSK 61
7.3.1 Company Profile 61
7.3.2 Product Information 62
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 62
7.4 Sanofi 64
7.4.1 Company Profile 64
7.4.2 Product Information 64
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 65
7.5 PharmAthene 66
7.5.1 Company Profile 66
7.5.2 Product Information 67
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 68
7.6 Bavarian Nordic 70
7.6.1 Company Profile 70
7.6.2 Product Information 71
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue 71
7.7 SIGA Technologies 73
7.7.1 Company Profile 73
7.7.2 Product Information 74
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue 74
7.8 Arbutus Biopharma 76
7.8.1 Company Profile 76
7.8.2 Product Information 77
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue 77
7.9 DynPort Vaccine 79
7.9.1 Company Profile 79
7.9.2 Product Information 80
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 80
7.10 Xoma Corporation 82
7.10.1 Company Profile 82
7.10.2 Product Information 83
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 84
7.11 Ichor Medical Systems 85
7.11.1 Company Profile 85
7.11.2 Product Information 86
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue 87
7.12 Aeolus Pharmaceuticals 88
7.12.1 Company Profile 88
7.12.2 Product Information 89
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue 90
7.13 Achaogen 91
7.13.1 Company Profile 91
7.13.2 Product Information 93
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 93
7.14 Elusys Therapeutics 95
7.14.1 Company Profile 95
7.14.2 Product Information 96
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue 96
7.15 Dynavax Technologies 98
7.15.1 Company Profile 98
7.15.2 Product Information 99
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue 99
7.16 Cleveland BioLabs 101
7.16.1 Company Profile 101
7.16.2 Product Information 102
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue 102
7.17 Soligenix 104
7.17.1 Company Profile 104
7.17.2 Product Information 105
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue 105
7.18 Alnylam Pharmaceuticals 107
7.18.1 Company Profile 107
7.18.2 Product Information 108
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue 108
8 Consumption Analysis of Biodefense 110
8.1 Therapeutic for Treating Smallpox 110
8.2 Therapeutic for Treating Anthrax 110
8.3 Therapeutic for Treating Botulinum toxins 111
8.4 Consumption Analysis of Biodefense 113
9 Key Consumers of Biodefense Industry 114
9.1 NIAID 114
9.2 DoD 114
9.3 DTRA 115
9.4 HHS 116
9.5 CDC 117
10 Development Trend of Biodefense Industry 2016-2021 118
10.1 Revenue Overview of Biodefense 2016-2021 118
10.2 Revenue Market Share Analysis of Biodefense 2016-2021 119
10.3 Global Biodefense Market Forecast by Product, by Segment 2016-2021 121
10.4 Revenue and Gross Margin of Biodefense 2016-2021 123
10.5 Market Size of Biodefense 2016-2021 123
11 Industry Chain Suppliers of Biodefense with Contact Information 125
11.1 Major Suppliers of Biodefense with Contact Information 125
11.2 Key Consumers of Biodefense with Contact Information 126
12 New Project Investment Feasibility Analysis of Biodefense 127
12.1 New Project SWOT Analysis of Biodefense 127
13 Conclusion of the Global Biodefense Industry Report 2015 128



List of Tables and Figures

Figure Picture of Biodefense Product (Tecovirimat) 1
Figure Structure of Biodefense Product (Tecovirimat) 2
Figure Classification of Biodefense 3
Figure Global Production Market Share of Biodefense by Type in 2015 3
Figure Application Fields of Biodefense Products 4
Figure 2015 Global Biodefense Major Applications Sales Share 5
Table Industry Policy of Biodefense 6
Table Industry News List of Biodefense 8
Figure of Bacillus Anthracis 10
Table Type of Biodefense 11
Figure of Variola Virus 12
Table Symptoms of Smallpox Disease 12
Figure of Clostridium Botulinum 14
Table Feature of Botulism 14
Table Type of Radiation Emergencies 15
Figure of Marburg Virus 16
Figure of Ebola Virus 17
Table Revenue (M USD) and Establish Time of Global Biodefense Key Manufacturers in 2015 18
Table Manufacturing Plants Distribution of Global Biodefense Key Manufacturers in 2015 19
Table Major Product of Global Biodefense Key Manufacturers in 2015 20
Table Global Biodefense Revenue Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) 2010-2015 (M USD) 21
Table Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) 2010-2015 (%) 21
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2010 (%) 22
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2011 (%) 23
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2012 (%) 24
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2013 (%) 25
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2014 (%) 26
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2015 (%) 27
Figure Global Biodefense against Anthrax Revenue (M USD) and Growth Rate 2010-2015 28
Figure Global Biodefense against Smallpox Revenue (M USD) and Growth Rate 2010-2015 29
Figure Global Biodefense against Botulism Revenue (M USD) and Growth Rate 2010-2015 30
Figure Global Biodefense against Radiation/Nuclear Revenue (M USD) and Growth Rate 2010-2015 31
Table Global Biodefense Revenue Analysis by Segment (USA Civilian, USA Military, Non-USA Market) 2010-2015 (M USD) 32
Table Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) 2010-2015 (%) 32
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2010 (%) 33
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2011 (%) 34
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2012 (%) 35
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2013 (%) 36
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2014 (%) 37
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2015 (%) 38
Figure USA Civilian Biodefense Revenue (M USD) and Growth Rate 2010-2015 39
Table USA Civilian Biodefense Market Share Analysis by Product 2010-2015 (%) 39
Figure USA Military Biodefense Revenue (M USD) and Growth Rate 2010-2015 40
Table USA Military Biodefense Market Share Analysis by Product 2010-2015 (%) 40
Figure Non-USA Market Biodefense Revenue (M USD) and Growth Rate 2010-2015 41
Table Non-USA Market Biodefense Market Share Analysis by Product 2010-2015 (%) 41
Table Global and Major Manufacturers Revenue Biodefense 2010-2015 (M USD) 42
Table Global Revenue Market Share of Major Biodefense Manufacturers 2010-2015 42
Figure Global Revenue (M USD) and Growth Rate of Biodefense 2010-2015 43
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2010 44
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2011 45
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2012 46
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2013 47
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2014 48
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2015 49
Table Gross Margin of Global Biodefense Major Manufacturers 2010-2015 50
Table Gross of Global Biodefense Major Manufacturers 2010-2015 51
Figure Gross Margin of Global Biodefense Major Manufacturers in 2014 52
Table Global Revenue (M USD) and Gross Margin of Biodefense 2010-2015 52
Table Market Size Overview of Biodefense 2010-2015 53
Figure Market Size Overview of Biodefense 2010-2015 53
Table Emergent Biosolutions Company Profile 54
Figure Biodefense Product Picture of Emergent Biosolutions 55
Table Biodefense Revenue (M USD) and Gross Margin of Emergent Biosolutions 2010-2015 56
Figure Biodefense Revenue (M USD) and Growth Rate of Emergent Biosolutions 2010-2015 56
Figure Biodefense Revenue (M USD) and Global Market Share of Emergent Biosolutions 2010-2015 57
Table Hytest Company Profile 57
Figure Specifications of Hytest 59
Table Biodefense Revenue (M USD) and Gross Margin of Hytest 2010-2015 59
Figure Biodefense Revenue (M USD) and Growth Rate of Hytest 2010-2015 60
Figure Biodefense Revenue (M USD) and Global Market Share of Hytest 2010-2015 60
Table GSK Company Profile 61
Table Biodefense Revenue (M USD) and Gross Margin of GSK 2010-2015 62
Figure Biodefense Revenue (M USD) and Growth Rate of GSK 2010-2015 63
Figure Biodefense Revenue (M USD) and Global Market Share of GSK 2010-2015 63
Table Sanofi Company Profile 64
Table Biodefense Revenue (M USD) and Gross Margin of Sanofi 2010-2015 65
Figure Biodefense Revenue (M USD) and Growth Rate of Sanofi 2010-2015 65
Figure Biodefense Revenue (M USD) and Global Market Share of Sanofi 2010-2015 66
Table PharmAthene Company Profile 66
Figure Biodefense Product Picture of PharmAthene 67
Table Biodefense Revenue (M USD) and Gross Margin of PharmAthene 2010-2015 68
Figure Biodefense Revenue (M USD) and Growth Rate of PharmAthene 2010-2015 69
Figure Biodefense Revenue (M USD) and Global Market Share of PharmAthene 2010-2015 69
Table Bavarian Nordic Company Profile 70
Table Biodefense Revenue (M USD) and Gross Margin of Bavarian Nordic 2010-2015 71
Figure Biodefense Revenue (M USD) and Growth Rate of Bavarian Nordic 2010-2015 72
Figure Biodefense Revenue (M USD) and Global Market Share of Bavarian Nordic 2010-2015 72
Table SIGA Technologies Company Profile 73
Figure Biodefense Product Specifications of SIGA Technologies 74
Table Biodefense Revenue (M USD) and Gross Margin of SIGA Technologies 2010-2015 74
Figure Biodefense Revenue (M USD) and Growth Rate of SIGA Technologies 2010-2015 75
Figure Biodefense Revenue (M USD) and Global Market Share of SIGA Technologies 2010-2015 75
Table Arbutus Biopharma Company Profile 76
Table Biodefense Revenue (M USD) and Gross Margin of Arbutus Biopharma 2010-2015 77
Figure Biodefense Revenue (M USD) and Growth Rate of Arbutus Biopharma 2010-2015 78
Figure Biodefense Revenue (M USD) and Global Market Share of Arbutus Biopharma 2010-2015 78
Table DynPort Vaccine Company Profile 79
Figure Biodefense Product Picture of DynPort Vaccine 80
Table Biodefense Revenue (M USD) and Gross Margin of DynPort Vaccine 2010-2015 80
Figure Biodefense Revenue (M USD) and Growth Rate of DynPort Vaccine 2010-2015 81
Figure Biodefense Revenue (M USD) and Global Market Share of DynPort Vaccine 2010-2015 81
Table Xoma Corporation Company Profile 82
Table Biodefense Revenue (M USD) and Gross Margin of Xoma Corporation 2010-2015 84
Figure Biodefense Revenue (M USD) and Growth Rate of Xoma Corporation 2010-2015 84
Figure Biodefense Revenue (M USD) and Global Market Share of Xoma Corporation 2010-2015 85
Table Ichor Medical Systems Company Profile 85
Figure Biodefense Product Picture of Ichor Medical Systems 86
Table Biodefense Revenue (M USD) and Gross Margin of Ichor Medical Systems 2010-2015 87
Figure Biodefense Revenue (M USD) and Growth Rate of Ichor Medical Systems 2010-2015 87
Figure Biodefense Revenue (M USD) and Global Market Share of Ichor Medical Systems 2010-2015 88
Table Aeolus Pharmaceuticals Company Profile 88
Figure Biodefense Product Picture of Aeolus Pharmaceuticals 89
Table Biodefense Revenue (M USD) and Gross Margin of Aeolus Pharmaceuticals 2010-2015 90
Figure Biodefense Revenue (M USD) and Growth Rate of Aeolus Pharmaceuticals 2010-2015 90
Figure Biodefense Revenue (M USD) and Global Market Share of Aeolus Pharmaceuticals 2010-2015 91
Table Achaogen Company Profile 91
Figure Biodefense Product Picture of Achaogen 93
Table Biodefense Revenue (M USD) and Gross Margin of Achaogen 2010-2015 93
Figure Biodefense Revenue (M USD) and Growth Rate of Achaogen 2010-2015 94
Figure Biodefense Revenue (M USD) and Global Market Share of Achaogen 2010-2015 94
Table Elusys Therapeutics Company Profile 95
Figure Biodefense Product Picture of Elusys Therapeutics 96
Table Biodefense Revenue (M USD) and Gross Margin of Elusys Therapeutics 2010-2015 96
Figure Biodefense Revenue (M USD) and Growth Rate of Elusys Therapeutics 2010-2015 97
Figure Biodefense Revenue (M USD) and Global Market Share of Elusys Therapeutics 2010-2015 97
Table Dynavax Technologies Company Profile 98
Figure Biodefense Product Picture of Dynavax Technologies 99
Table Biodefense Revenue (M USD) and Gross Margin of Dynavax Technologies 2010-2015 99
Figure Biodefense Revenue (M USD) and Growth Rate of Dynavax Technologies 2010-2015 100
Figure Biodefense Revenue (M USD) and Global Market Share of Dynavax Technologies 2010-2015 100
Table Cleveland BioLabs Company Profile 101
Figure Biodefense Product Picture of Cleveland BioLabs 102
Table Biodefense Revenue (M USD) and Gross Margin of Cleveland BioLabs 2010-2015 102
Figure Biodefense Revenue (M USD) and Growth Rate of Cleveland BioLabs 2010-2015 103
Figure Biodefense Revenue (M USD) and Global Market Share of Cleveland BioLabs 2010-2015 103
Table Soligenix Company Profile 104
Figure Biodefense Product Picture of Soligenix 105
Table Biodefense Revenue (M USD) and Gross Margin of Soligenix 2010-2015 105
Figure Biodefense Revenue (M USD) and Growth Rate of Soligenix 2010-2015 106
Figure Biodefense Revenue (M USD) and Global Market Share of Soligenix 2010-2015 106
Table Alnylam Pharmaceuticals Company Profile 107
Figure Biodefense Product Picture of Alnylam Pharmaceuticals 108
Table Biodefense Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals 2010-2015 108
Figure Biodefense Revenue (M USD) and Growth Rate of Alnylam Pharmaceuticals 2010-2015 109
Figure Biodefense Revenue (M USD) and Global Market Share of Alnylam Pharmaceuticals 2010-2015 109
Table Consumption Analysis of Biodefense 2010-2015 by Segment 113
Figure Consumption Volume (M USD) Analysis of Biodefense in 2015 113
Table NIAID Profile 114
Table DoD Profile 114
Table DTRA Profile 115
Table HHS Profile 116
Table CDC Profile 117
Figure Global Revenue (M USD) and Growth Rate of Biodefense 2016-2021 118
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2016 119
Figure Global Revenue Market Share of Major Biodefense Manufacturers in 2021 120
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2016 (%) 121
Figure Global Biodefense Revenue Market Share Analysis by Product (Anthrax, Smallpox, Botulism, Radiation/Nuclear, Other) in 2021 (%) 122
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2016 (%) 122
Figure Global Biodefense Revenue Market Share Analysis by Segment (USA Civilian, USA Military, Non-USA Market) in 2021 (%) 123
Table Global Revenue (M USD) and Gross Margin of Biodefense 2016-2021 123
Table Market Size Overview of Biodefense 2016-2021 123
Figure Market Size Overview of Biodefense 2016-2021 124
Table Major Suppliers of Biodefense with Contact Information 125
Table Key Consumers of Biodefense with Contact Information 126
Table New Project SWOT Analysis of Biodefense 127

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.